Essex Woodlands Health Ventures Viii, L.L.C. Insider Profile
4 Followers
Essex Woodlands Health Ventures Viii, L.L.C., Ten Percent Owner at Catalyst Biosciences Inc, holds 108.33K shares in Entellus Medical (Ticker: ENTL), holds 1.18M shares in Catalyst Biosciences Inc (Ticker: CBIO). Most recently, Essex Woodlands Health Ventures Viii, L.L.C. Sold ― shares of Entellus Medical on Feb 02, 2017 for an estimated value of 9.89M.
Essex Woodlands Health Ventures Viii, L.L.C. insider profile FAQ
What is the percentage of profitable transactions made by Essex Woodlands Health Ventures Viii, L.L.C.?
The percentage of profitable transactions made by Essex Woodlands Health Ventures Viii, L.L.C. is 0%.
What is the average return per transaction made by Essex Woodlands Health Ventures Viii, L.L.C.?
The average return per transaction made by Essex Woodlands Health Ventures Viii, L.L.C. is -50.00%.
What stocks does Essex Woodlands Health Ventures Viii, L.L.C. hold?
Essex Woodlands Health Ventures Viii, L.L.C. holds: CBIO, ENTL stocks.
What was Essex Woodlands Health Ventures Viii, L.L.C.’s latest transaction?
Essex Woodlands Health Ventures Viii, L.L.C. latest transaction was an Informative Sell of 9.89M.
What was Essex Woodlands Health Ventures Viii, L.L.C.'s most profitable transaction?
Essex Woodlands Health Ventures Viii, L.L.C.’s most profitable transaction was an Informative Buy of ENTL stock on February 3, 2015. The return on the trade was -21.80%.
What is Essex Woodlands Health Ventures Viii, L.L.C.'s role in Catalyst Biosciences Inc?
Essex Woodlands Health Ventures Viii, L.L.C.'s role in Catalyst Biosciences Inc is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.